New Class of Medication That Treat Migraine Attacks
People suffering from migraines can feel throbbing pain which can range from mild to severe pain that can interfere with your daily activities.
Currently, many neurologists do yearly MRIs to monitor multiple sclerosis disease activity. There is a new blood test that may monitor multiple sclerosis disease activity better in clinically stable patients.
The test is called sNfL (serum neurofilament). It measures the breakdown of a certain part of neurons, which occurs when multiple sclerosis is attacking the nervous system. A recent study (https://nn.neurology.org/content/nnn/7/4/e714.full.pdf) shows that patients with low levels of sNfL have a very low probability of recent MS activity on yearly MRI. This new test may be a convenient alternative to MRI in monitoring disease activity.